Click the above link to access the complete Digital Edition of the November 2013 issue, with all text, charts and pictures.
Anna Protopapas, President, Millennium: The Takeda Oncology Co.
As customers use Triple Aim to drive healthcare quality, pharma will need to develop integrated offerings
Brands that put the user first when building digital assets experienced a 50% drop in user errors
Keeping up with quality programs often feels like a safari in a jungle of government paperwork
News on Clearpath Health Communications, Publicis,Omnicom, Incubate and Lilly
When an FDA advisory panel met last month to vote on whether to recommend approval of Sanofi's MS drug Lemtrada, patient opinion leaders had already voiced their view.
In 2014, the "new healthcare marketing" will become more discontinuous from the old
Eli Lilly promised a further easing in commercial outlays as it draws down sales force activity and advertising spend for two blockbusters whose patent expiries are drawing nigh.
News from Pfizer, the National Institute on Drug Abuse, HealthTap and LEO Pharma